Next Article in Journal
A Chemical Genetics Strategy That Identifies Small Molecules Which Induce the Triple Response in Arabidopsis
Next Article in Special Issue
Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors
Previous Article in Journal
Studies on the Anti-Oxidative Function of trans-Cinnamaldehyde-Included β-Cyclodextrin Complex
Previous Article in Special Issue
Inhibition by Commercial Aminoglycosides of Human Connexin Hemichannels Expressed in Bacteria

Amikacin: Uses, Resistance, and Prospects for Inhibition

Center for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA 92831, USA
Author to whom correspondence should be addressed.
Molecules 2017, 22(12), 2267;
Received: 27 November 2017 / Revised: 13 December 2017 / Accepted: 14 December 2017 / Published: 19 December 2017
(This article belongs to the Special Issue Recent Development on the New Applications of Aminoglycosides)
Aminoglycosides are a group of antibiotics used since the 1940s to primarily treat a broad spectrum of bacterial infections. The primary resistance mechanism against these antibiotics is enzymatic modification by aminoglycoside-modifying enzymes that are divided into acetyl-transferases, phosphotransferases, and nucleotidyltransferases. To overcome this problem, new semisynthetic aminoglycosides were developed in the 70s. The most widely used semisynthetic aminoglycoside is amikacin, which is refractory to most aminoglycoside modifying enzymes. Amikacin was synthesized by acylation with the l-(−)-γ-amino-α-hydroxybutyryl side chain at the C-1 amino group of the deoxystreptamine moiety of kanamycin A. The main amikacin resistance mechanism found in the clinics is acetylation by the aminoglycoside 6′-N-acetyltransferase type Ib [AAC(6′)-Ib], an enzyme coded for by a gene found in integrons, transposons, plasmids, and chromosomes of Gram-negative bacteria. Numerous efforts are focused on finding strategies to neutralize the action of AAC(6′)-Ib and extend the useful life of amikacin. Small molecules as well as complexes ionophore-Zn+2 or Cu+2 were found to inhibit the acetylation reaction and induced phenotypic conversion to susceptibility in bacteria harboring the aac(6′)-Ib gene. A new semisynthetic aminoglycoside, plazomicin, is in advance stage of development and will contribute to renewed interest in this kind of antibiotics. View Full-Text
Keywords: aminoglycosides; antibiotic resistance; amikacin; aminoglycoside modifying enzymes; antisense aminoglycosides; antibiotic resistance; amikacin; aminoglycoside modifying enzymes; antisense
Show Figures

Graphical abstract

MDPI and ACS Style

Ramirez, M.S.; Tolmasky, M.E. Amikacin: Uses, Resistance, and Prospects for Inhibition. Molecules 2017, 22, 2267.

AMA Style

Ramirez MS, Tolmasky ME. Amikacin: Uses, Resistance, and Prospects for Inhibition. Molecules. 2017; 22(12):2267.

Chicago/Turabian Style

Ramirez, Maria S., and Marcelo E. Tolmasky 2017. "Amikacin: Uses, Resistance, and Prospects for Inhibition" Molecules 22, no. 12: 2267.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop